Gatifloxacin Anhydrous: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Gatifloxacin Anhydrous. Educational only — not medical advice.
Labeled uses
Gatifloxacin ophthalmic solution 0.5 % is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic gram-positive bacteria: Staphylococcus aureus Staphylococcus epidermidis Streptococcus mitis group* Streptococcus oralis* Streptococcus pneumoniae Aerobic gram-negative bacteria: Haemophilus influenzae *Efficacy for these organisms were studied in fewer than 10 infections.
Source: FDA labeling via NIH DailyMed (set 826cf8c4…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.